Cyprus: Manual Of Industrial Property



[A] Kinds of Patents

– National patent

– European patent

[B] Duration of Patents

– 20 years from the date of filing

[C] Patentable / Not Patentable

– To be patentable, an invention must be new, involve an inventive step and be applicable in industry.

– The exceptions of rule 39 PCT apply.

– Also not patentable are computer programs; processes for cloning human beings; processes for modifying the germ line genetic identity of human beings; uses of human embryos for industrial or commercial purposes.

– Processes for modifying the genetic identity of animals, which are likely to cause them suffering without any substantial medical benefit to man or animal, and also animals resulting from such processes.

[D] Novelty

– Absolute novelty is required.

[E] Requirements and Procedure

– Filing language: Any

– Language of translation: Greek

– Time limit for filing translation: 4 months from filing

– Patent applications are examined as to form only but not as to substance.

[F] Specific Aspects of Regional Patents

– Validation of European Patents in Cyprus is possible.

[G] Specific Aspects of International Patent Applications (PCT)

– The only way to extend a PCT international application to Cyprus is by way of a European Patent validated in Cyprus.

[H] Governmental Websites


[A] Conventions and Legislation

[1] Conventions

– Paris Convention (International Union), 1883–1967 (Cyprus is bound by the Stockholm text of 1967 since 3 April 1984);

– Hague Convention Abolishing the Requirement of Legalization for Foreign Public Documents, 1961, since 30 April 1973;

– Convention Establishing the World Intellectual Property Organization (hereinafter 'WIPO Convention'), 1967, since 26 October 1984;

– Patent Cooperation Treaty (PCT), 1970, since 1 April 1998;

– European Patent Convention, 1973, since 1 April 1998;

– WTO TRIPS Agreement, since 30 July 1985;

– Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure;

– EU Regulation No. 1768/92 EC of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products;

– EU Regulation No. 2100/94 EC of 27 July 1994 on Community plant variety rights;

– EU Regulation (EC) 1610/96 of 23 July 1996 concerning the creation of a supplementary protection certificate for plant protection products;

– EU Directive 98/44/EC of 6 July 1998 on the legal protection of biotechnological inventions;

– EU Directive 2004/27/EC of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use;

– EU Directive 2004/48/EC of 29 April 2004 on the enforcement of intellectual property rights;

– EU Regulation (EC) No. 1901/2006 of 12 December 2006 on medicinal products for paediatric use;

– EU Regulation (EU) No. 1257/2012 of 17 December 2012 implementing enhanced cooperation in the area of the creation of unitary patent protection (not yet in force);

– EU Regulation (EU) No. 1260/2012 of 17 December 2012 implementing enhanced cooperation in the area of the creation of unitary patent protection with regard to the applicable translation arrangements (not yet in force); and

– Agreement of 19 February 2013 on a Unified Patent Court (not yet in force).

[2] Laws

– Patents Law of 1998 (as amended);

– Patents Rules 1999 (as amended);

– Protection of New Plant Varieties Law No. 21(I)/2004, which took effect in Cyprus on 1 May 2004;

– The Legal Protection of Topographies of Semiconductor Products Law No. 5(I)/2002, as amended by The Legal Protection of Topographies of Semiconductor Products (Amendment) Law of 2006, 120(I)/2006; and

– Law No. 163(I)/2002, The Patents (Amendment) Law of 2002.

[B] Kinds of Patents

– National patents

– European patents.

Depending on ratification of the Agreement on a Unified Patent Court, a European patent granted after the entry into force may, at the applicant's choice, alternatively be registered as a European patent with unitary effect for the whole of the European Union except (as currently expected) Spain and Poland ('EU patent'). See for more details the chapters 'European Union' and 'European Patent System' in the section 'Patents' under 'Conventions and Legislation'.

[C] Duration of Patents

The duration of national patents is twenty years from the filing date of the patent, subject to the payment of annual fees.

[1] Supplementary protection certificate

The term of protection of an invention relating to a pharmaceutical covered by a patent may be extended in Cyprus (by the grant of a supplementary protection certificate) with a period equal to that lapsed between the date of filing the patent application and the date of grant of the first marketing authorization in Cyprus, less five years. The maximum duration of the supplementary protection certificate is five years.

If the first marketing authorization in Cyprus was granted within five years from the date of filing the patent application, no supplementary protection certificate can be obtained. If the first such authorization in Cyprus was granted between five and ten years from the date of filing the patent application, the duration of the certificate may be up to five years, depending on when that authorization was granted. If the first such authorization in Cyprus was granted between ten and twenty years from the date of filing the patent application, a certificate with a duration of five years may be obtained. The period of validity of the certificate runs from the expiration of the basic patent.

The possibility of extension applies both to national Cyprus patents and to European patents valid in Cyprus. Products protected by a patent in Cyprus which, before they may be brought on the market as a medicinal product, are subjected to an administrative authorization procedure in Cyprus, may be the subject of a supplementary protection certificate. Medicinal product in this context means any substance or combination of substances, presented for treating or preventing disease in human beings or animals, and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in human beings or animals. Product in this context means the active ingredient or combination of active ingredients of a medicinal product. For obtaining a supplementary protection certificate, an application must be filed with the Registrar in Cyprus.

Such certificate may be obtained only provided that:

(1) at the date the certificate is applied for the product concerned is protected by a basic patent still in force in Cyprus, which patent protects the product, a process to obtain the product, or an application of the product;

(2) for bringing into the trade of the product concerned as a medicine a valid authorization has been granted in Cyprus;

(3) no previous supplementary protection certificate has been obtained for the product; and

(4) the authorization meant under (2) is the first authorization to put the product on the market in Cyprus as a medicinal product.

A supplementary protection certificate may be applied for by the owner of the basic patent or his or her legal successor or assignee. The certificate must be applied for within six months from the date on which the first marketing authorization for bringing the product concerned on the market as a medicinal product in Cyprus was granted. However, if that authorization was granted before grant of the basic patent, the certificate must be applied for within six months from the date on which the patent is granted.

To continue reading this article, please click here.

Previously published by Kluwer Law International

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.